Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Skanska constructs university performing arts center in Virginia, USA, for USD 73M, about SEK 730M
-
Hoffmann Green Releases its Half-Year Results with Record Increase in Production Volumes
-
Apple Koregaon Park opens to customers this Thursday, September 4, in Pune
-
SnapInsta Strengthens Its Position as a Global Leader in Instagram Download Technology
-
Data Analytics Shapes Modern Investment Strategies
-
2025 H2 Bitcoin Market Outlook: Mint Miner Cloud Mining Becomes a New Option for Investors
-
2025 H2 Bitcoin Market Outlook: Mint Miner Cloud Mining Becomes a New Option for Investors
-
2025 H2 Bitcoin Market Outlook: Mint Miner Cloud Mining Becomes a New Option for Investors
-
Aegon successfully sells 12.5 million shares in a.s.r.
-
CGTN: What to choose between war and peace? China's V-Day message to the world is loud and clear
-
FLSmidth: Transactions under share buy-back programme
-
Sampo plc’s share buybacks 2 September 2025
-
UK Co-ops Transform Retail With SymphonyAI’s AI-Powered Connected Retail Platform
-
HIVE Digital Technologies Completes Phase 2 of Its Yguazú Project in Paraguay Reaching 18 EH/s, Producing 8 Bitcoin per Day from Hydroelectric Power
-
Nova Announces Pricing of Upsized Private Offering of $650 Million of 0.00% Convertible Senior Notes due 2030
-
CTP expands partnership with Hisense Group as lease for new 15,000 sqm facility in Budapest is signed
-
Dalton Maag Challenges OEM Font Status Quo with MetricsMatch
-
Chunghwa Telecom Earns Frost & Sullivan's 2025 Taiwan Technology Innovation Leadership Recognition in the 5G Industry
-
Start of Day Message
-
NMD Pharma Expands Senior Leadership Team with the Appointment of Ana de Vera as Chief Medical Officer
-
Valneva Reports Further Positive Phase 2 Safety and Immunogenicity Results for Lyme Disease Vaccine Candidate
-
Pluxee acquires Skipr and reinforces its employee mobility benefits offering in Belgium and France
-
dsm-firmenich achieves target of 100% purchased renewable electricity
-
Elis announces a 2025 “Elis for All” employee share ownership plan
-
HAFNIA LIMITED: Ex Dividend USD 0.1210 on the Oslo Stock Exchange Today
-
Lyft Announces Pricing of Offering of $450 million of Convertible Senior Notes
-
BMC Expands Global SaaS Delivery in Australia with Availability on AWS
-
Prince Silver Announces Non-brokered Private Placement
-
Graphano Applauds Canada's New Major Projects Office as Catalyst for North American Graphite Supply
-
Dynamic Growth Leads C2N Diagnostics to Expand St. Louis Headquarters to Meet Global Need for Answers to Alzheimer’s Disease
-
The Federative Republic of Brazil Announces Pricing of its New Bonds Offering
-
DXC Advances AI Innovation in Automotive and Manufacturing through Startup Collaboration
-
Comcast Technology Solutions to Create Philadelphia Flyers Mobile App and Web Fan Experience
-
Cheongju Craft Biennale 2025 <Re_Crafting Tomorrow> 60 Days of Grandeur Begin on September 4
-
Liberty Personal Loans Help Australians Manage Medical Costs
-
SERES Posts Robust H1 2025 Results: Revenue Hits CNY 62.4 Billion, Net Profit Up 81% to CNY 2.94 Billion, R&D Investment Soars nearly 155%
-
New York-Based dental clinic Revitta Rebrands as VisoDent NY
-
SINBON Strengthens Strategic Partnership with Swobbee to Advance Sustainable Urban Mobility
-
Honda Running Team Member, Nagiya Mori, Selected to Represent Japan in World Athletics Championships Tokyo 25 (WCH Tokyo 25) Men's 5000m Event
-
Faraday Future Launches FX Super One National Co-Creation and Sales Events with Positive Response in New York, Boston, and Los Angeles
-
Kovo+ Announces Corporate Update
-
ASK4SAM Cements Role As Best NYC Personal Injury Lawyers for Car Accidents in Queens & Bronx with 550th Google Review
-
ASK4SAM Cements Role As Best NYC Personal Injury Lawyers for Car Accidents in Queens & Bronx with 550th Google Review
-
Commvault Announces Pricing of Upsized Convertible Senior Notes Offering
-
OPIM and Qraft Capital Launch AI-Driven Quantitative Strategy Fund for Global Investors
-
Rolling sBLA initiated to the U.S. FDA for Leqembi® Iqlik™ (lecanemab-irmb) as a subcutaneous starting dose for the treatment of early Alzheimer's disease under Fast Track status
-
"The Authenticity," Curated by Cope2 Featuring Shepard Fairey, Danny Cortes and Many more... at One Art Space, Tribeca, NY
-
WeRide to Participate in September Investor Conferences
-
BioSig Technologies Supplements Clarification on Recent Schedule 14A Filing. Closing of Merger with Streamex Exchange Corporation Not Affected
-
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's
